BibTex RIS Cite

Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi

Year 2004, Volume: 2 Issue: 1, 15 - 20, 01.03.2004

Mustafa K. Hacımustafaoğlu

Abstract

Çocuklarda antibiyotik kullanım ilkeleri genellikle erişkinlerdekine benzerdir, ancak bazı konularda büyük farklılıklar olabilir. Çocuğun dinamik doğası bu farklılıklarda rol oynar.

References

  • 1. Nelson WE, Behrman RE, Kliegman RM, Arvin AM, editors. The Textbook of Pediatrics. 15 th edition. Philadelphia: WB Sounders Company, 1996.
  • 2. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J 1997; 16:556- 9.
  • 3. Schentog JJ. Clinical significance of antibiotics tissue penetration. Clin Pharmacokinet 1989; 16(suppl 1): 25-31.
  • 4. Drusano GL. Role of pharmacokinetics in outcome of infections. Antimicrob Agents Chemother 1988; 32:289-97.
  • 5. Pichichero ME. Empiric antibiotic selection criteria for respiratory infections in pediatric practice. Pediatr Infect Dis J 1997; 16:560-4.
  • 6. Dagan R, Schvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J 1994; 13:689-90.
  • 7. Hacımustafaoğlu M, Çelebi S, Sağlam H, Ercan ı, Çakar N, Yıldız Z. Çocuklarda ayaktan enfeksiyon tedavisinde antibiyotiklerin tolere edilmesi ve klinik yanıtların değerlendirilmesi. XXXV.Ulusal Pediatri Kongresi Özet Kitabı, 19-23 Mayıs, 1999, Ankara.
  • 8. O. Kayaalp. Rasyonel tedavi yönünden t›bbi farmakoloji. 7.Baskı, Güneş Kitabevi, 1994, Ankara.
  • 9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th edition. Baltimore: Williams and Wilkins, 1994.
  • 10. Moellering RC. Principles of Anti ‹nfektive Therapy. In: Mandell GL, Bennett JE, Dolin R, (eds). Principles and Practice of Infectious Diseases, 4th edition, New York: Churchill Livingstone, 1995: 205-6.
  • 11. Gilbert DN, Moellering RC, Sande MA. Guide to antimicrobial therapy. 28 th edition. Vienna: Sanford Guide; 1998.
  • 12. American Academy of Pediatrics. Peter G, ed. 1997 Red Book: Report of the committee on Infectious Diseases. 24 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997: 410-9, 593-603.
  • 13. Gerding DN, Hughes CE, Bamberger DM, Foxworth J, Larson TA. Extravascular antimicrobial distribution and the respective blood concentrations in humans. In: Lorian V, (ed.). Antibiotics in Laboratory Medicine. 4th edition. Baltimore: Williams and Wilkins, 1996: 835-99.
  • 14. Giamarelly H, Kolokythas E, Petrikkos G, Garis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989 87: (Suppl 5A): 495-515.
  • 15. Bergan T, Engeset A, Olzewski W, et al. Extravascular penetration of highly protein bound flucloxacillin. Antimicrob Agents Chemother 1986; 30:729-32.
  • 16. Gerding DN, Peterson LR. Serum protein binding and extravascular distribution of antimicrobials. Antimicrob Agents Chemother 1985; 15:136-8.
  • 17. Wise R, Gillert AP, Cadge B, Durhan SR, Bater S. The influence of protein binding upon tissue fluid levels of six beta lactam antibiotics. J Infect Dis 1980; 142: 77-82.
  • 18. Rolinson GN, The significance of protein binding of antibiotics in bacterial chemotherapy. J Antimicrob Chemother 1980; 6:311-7.
  • 19. Scaglione F, Raichi M Fraschini F. Serum protein binding and extravasculer diffusion of methixyimino cephalosporins. J Antimicrob Chemother 1990; 26(Suppl A): 1-10.
  • 20. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11:470-82.
  • 21. Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 1986; 18: 381-8.
  • 22. Rosenfeld RM. An evidence based approach to treating otitis media. Pediatr Clin North Am 43; 1996: 1165-81.
  • 23. Jacobs MR. Penicillin resistant S. Pneumoniae in acute otitis media. Pediatr Infect Dis J 1998; 17:947-52.
  • 24. Yuk JH, Nightingale GH, Quintitiani R. Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet 1989; 17:223-35.
  • 25. Fraschini F, Scaglione F, Pintucci G et al.The diffusion of clarithromycin and roxithomycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991; 27: (suppl A):61-5.
  • 26. Martin JR, Johnson P, Miller MF. Reuptake, accumulation and egress of erytromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 1985; 27: 314-9.
  • 27. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed.). Antibioics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996
  • 28. Grayson MC, Elioponlos GM, Ferrano MJ, Moellering RC. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8:888-9.
  • 29. Sable CA, Scheld NM. Theoretical and practical considerations of antibiotic therapy for bacterial meningitidis. J Antibiotic Chemother 1992; 45:96-117.
  • 30. Ream TRJr, Allen JC. Blood, brain and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflame meninges. Antimicrob Agents Chemother 1977;12: 710-6.
  • 31. Johnson CC. Invitro testing: Correlation of bacterial susceptibility, body fluid levels and effectiveness of antimicrobial therapy. In: Lorian V (ed.). Antibiotics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996: 813-34.
  • 32. Schuler C, Golper TA, Bennett WM. Prescribing drugs in renal disease. In: Brenner BM, (ed.). The Kidney. 5 th edition. Philadelphia: WB Sounders Company, 1996:658-89.

Year 2004, Volume: 2 Issue: 1, 15 - 20, 01.03.2004

Mustafa K. Hacımustafaoğlu

Abstract

References

  • 1. Nelson WE, Behrman RE, Kliegman RM, Arvin AM, editors. The Textbook of Pediatrics. 15 th edition. Philadelphia: WB Sounders Company, 1996.
  • 2. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J 1997; 16:556- 9.
  • 3. Schentog JJ. Clinical significance of antibiotics tissue penetration. Clin Pharmacokinet 1989; 16(suppl 1): 25-31.
  • 4. Drusano GL. Role of pharmacokinetics in outcome of infections. Antimicrob Agents Chemother 1988; 32:289-97.
  • 5. Pichichero ME. Empiric antibiotic selection criteria for respiratory infections in pediatric practice. Pediatr Infect Dis J 1997; 16:560-4.
  • 6. Dagan R, Schvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J 1994; 13:689-90.
  • 7. Hacımustafaoğlu M, Çelebi S, Sağlam H, Ercan ı, Çakar N, Yıldız Z. Çocuklarda ayaktan enfeksiyon tedavisinde antibiyotiklerin tolere edilmesi ve klinik yanıtların değerlendirilmesi. XXXV.Ulusal Pediatri Kongresi Özet Kitabı, 19-23 Mayıs, 1999, Ankara.
  • 8. O. Kayaalp. Rasyonel tedavi yönünden t›bbi farmakoloji. 7.Baskı, Güneş Kitabevi, 1994, Ankara.
  • 9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th edition. Baltimore: Williams and Wilkins, 1994.
  • 10. Moellering RC. Principles of Anti ‹nfektive Therapy. In: Mandell GL, Bennett JE, Dolin R, (eds). Principles and Practice of Infectious Diseases, 4th edition, New York: Churchill Livingstone, 1995: 205-6.
  • 11. Gilbert DN, Moellering RC, Sande MA. Guide to antimicrobial therapy. 28 th edition. Vienna: Sanford Guide; 1998.
  • 12. American Academy of Pediatrics. Peter G, ed. 1997 Red Book: Report of the committee on Infectious Diseases. 24 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997: 410-9, 593-603.
  • 13. Gerding DN, Hughes CE, Bamberger DM, Foxworth J, Larson TA. Extravascular antimicrobial distribution and the respective blood concentrations in humans. In: Lorian V, (ed.). Antibiotics in Laboratory Medicine. 4th edition. Baltimore: Williams and Wilkins, 1996: 835-99.
  • 14. Giamarelly H, Kolokythas E, Petrikkos G, Garis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989 87: (Suppl 5A): 495-515.
  • 15. Bergan T, Engeset A, Olzewski W, et al. Extravascular penetration of highly protein bound flucloxacillin. Antimicrob Agents Chemother 1986; 30:729-32.
  • 16. Gerding DN, Peterson LR. Serum protein binding and extravascular distribution of antimicrobials. Antimicrob Agents Chemother 1985; 15:136-8.
  • 17. Wise R, Gillert AP, Cadge B, Durhan SR, Bater S. The influence of protein binding upon tissue fluid levels of six beta lactam antibiotics. J Infect Dis 1980; 142: 77-82.
  • 18. Rolinson GN, The significance of protein binding of antibiotics in bacterial chemotherapy. J Antimicrob Chemother 1980; 6:311-7.
  • 19. Scaglione F, Raichi M Fraschini F. Serum protein binding and extravasculer diffusion of methixyimino cephalosporins. J Antimicrob Chemother 1990; 26(Suppl A): 1-10.
  • 20. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11:470-82.
  • 21. Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 1986; 18: 381-8.
  • 22. Rosenfeld RM. An evidence based approach to treating otitis media. Pediatr Clin North Am 43; 1996: 1165-81.
  • 23. Jacobs MR. Penicillin resistant S. Pneumoniae in acute otitis media. Pediatr Infect Dis J 1998; 17:947-52.
  • 24. Yuk JH, Nightingale GH, Quintitiani R. Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet 1989; 17:223-35.
  • 25. Fraschini F, Scaglione F, Pintucci G et al.The diffusion of clarithromycin and roxithomycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991; 27: (suppl A):61-5.
  • 26. Martin JR, Johnson P, Miller MF. Reuptake, accumulation and egress of erytromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 1985; 27: 314-9.
  • 27. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed.). Antibioics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996
  • 28. Grayson MC, Elioponlos GM, Ferrano MJ, Moellering RC. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8:888-9.
  • 29. Sable CA, Scheld NM. Theoretical and practical considerations of antibiotic therapy for bacterial meningitidis. J Antibiotic Chemother 1992; 45:96-117.
  • 30. Ream TRJr, Allen JC. Blood, brain and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflame meninges. Antimicrob Agents Chemother 1977;12: 710-6.
  • 31. Johnson CC. Invitro testing: Correlation of bacterial susceptibility, body fluid levels and effectiveness of antimicrobial therapy. In: Lorian V (ed.). Antibiotics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996: 813-34.
  • 32. Schuler C, Golper TA, Bennett WM. Prescribing drugs in renal disease. In: Brenner BM, (ed.). The Kidney. 5 th edition. Philadelphia: WB Sounders Company, 1996:658-89.
There are 32 citations in total.

Details

Primary Language Turkish
Journal Section Research Article
Authors

Mustafa K. Hacımustafaoğlu

Publication Date March 1, 2004
Published in Issue Year 2004 Volume: 2 Issue: 1

Cite

APA Hacımustafaoğlu, M. K. (2004). Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi. Güncel Pediatri, 2(1), 15-20.
AMA Hacımustafaoğlu MK. Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi. Güncel Pediatri. March 2004;2(1):15-20.
Chicago Hacımustafaoğlu, Mustafa K. “Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi”. Güncel Pediatri 2, no. 1 (March 2004): 15-20.
EndNote Hacımustafaoğlu MK (March 1, 2004) Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi. Güncel Pediatri 2 1 15–20.
IEEE M. K. Hacımustafaoğlu, “Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi”, Güncel Pediatri, vol. 2, no. 1, pp. 15–20, 2004.
ISNAD Hacımustafaoğlu, Mustafa K. “Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi”. Güncel Pediatri 2/1 (March 2004), 15-20.
JAMA Hacımustafaoğlu MK. Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi. Güncel Pediatri. 2004;2:15–20.
MLA Hacımustafaoğlu, Mustafa K. “Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi”. Güncel Pediatri, vol. 2, no. 1, 2004, pp. 15-20.
Vancouver Hacımustafaoğlu MK. Antibiyotiklerin Farmakolojik Özelliklerinin Akılcı Antibiyotik Kullanımındaki Önemi. Güncel Pediatri. 2004;2(1):15-20.